An ongoing dialogue on HIV/AIDS, infectious diseases,
October 23rd, 2011
TB, Timing of Antiretroviral Therapy, and Being a Lumper Rather Than a Splitter
Three key papers on timing of ART in patients with TB have just been published in the New England Journal of Medicine.
Fortunately, Carlos Del Rio has done a bang-up job summarizing them in Journal Watch AIDS Clinical Care.
And if you’re wondering how we got our title for Carlos’ piece, here’s an e-mail between our Executive Editor to me a few weeks ago:
Hi Paul-
Later this month, NEJM will be publishing three articles on the timing of ART initiation relative to TB treatment. I assume we should cover these?
Cath
To which I responded:
Yep. And they all can be summarized as follows: “TB + low CD4 = start ART sooner rather than later”.
Yes, there are lots more data from these studies than this simple equation, but my response was a reminder that, despite being a thrice-certified ID specialist, I tend to be more of a lumper rather than a splitter — which makes me feel somewhat deficient in our field.
Oh well.
Of course even the less detail-obsessed ID docs like me probably score pretty high on the OCD-meter, so I can take some comfort in that.
Categories: HIV, Infectious Diseases, Patient Care, Research
Tags: antiretroviral therapy, ART, HIV, New England Journal of Medicine, TB, tuberculosis
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing
- Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country
- Sometimes You Just Need to Get Input from a Real Human Being
- Mystifying Abbreviations — Infectious Diseases Edition
- Rabies Is Terrifying — and the Challenge of Managing a Low Risk of a Dreadful Disease
-
From the Blog — Most Recent Articles
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing February 17, 2026
- Sometimes You Just Need to Get Input from a Real Human Being February 12, 2026
- Mystifying Abbreviations — Infectious Diseases Edition February 4, 2026
- Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country January 27, 2026
- Rabies Is Terrifying — and the Challenge of Managing a Low Risk of a Dreadful Disease January 21, 2026
FROM NEJM — Recent Infectious Disease Articles- Subacute Sclerosing Panencephalitis after Measles Infection February 21, 2026A 7-year-old boy was brought to a hospital with a 3-month history of cognitive deterioration and seizures. He had contracted measles at 7 months of age while living in an area where the infection is endemic.
- AI-Enabled Precision-Education Systems — Transforming Lifelong Learning in Medicine February 21, 2026Trainees’ paths to safe, independent practice are variable. Artificial intelligence could help accelerate implementation of competency-based medical education to support individualized development.
- Revival of Ethionamide by Alpibectir February 19, 2026Ethionamide has been used to treat tuberculosis for decades, but dose-dependent toxic effects have limited its use. In this trial, alpibectir enabled the ethionamide dose to be reduced by two thirds.
- Peritoneal Coccidioidomycosis February 19, 2026A 23-year-old man presented with a 2-month history of unintentional weight loss and worsening abdominal pain and distention. He had recently moved to Arizona from a remote Pacific island.
- Reducing Tobacco Use Worldwide: Tobacco Cessation among Nondaily and Low-Intensity Smokers — Challenges and Opportunities in Latin America February 19, 2026In Latin America, though overall smoking rates have declined, nondaily and low-intensity smoking are increasingly common, and tobacco-cessation resources remain underdeveloped in many countries.
- Subacute Sclerosing Panencephalitis after Measles Infection February 21, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
